Office of Research & Development |
![]() ![]() |
Project Number: | IK1CX002089-01 |
Title: | Neurometabolic mechanisms of aberrant resting brain activity in schizophrenia |
Principal Investigator: | Michael Jacob |
Location: | San Francisco, CA |
Congressional District Code: | 12 |
Research Service: | Clinical Science R&D |
Project Period: | April 2020 - March 2022 |
FY 2021 Funding Amount: | $245,351 |
Total Award Amount (all years): |
$493,018 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Schizophrenia is a debilitating psychiatric illness that increases the risk for medical comorbidities, such as metabolic syndrome, diabetes, and cardiovascular disease. Metabolic comorbidities are the leading causes of premature death for veterans with schizophrenia. Although cellular and genetic studies have suggested that metabolic impairments may underlie neural dysfunction, studies in clinical neuroscience are limited. Resting state, functional magnetic resonance imaging (fMRI), is widely us... |